Response of lung NK1.1-positive natural killer cells to experimental sepsis in mice

Shock

Volumn 22, Issue 1, 2004, Pages 40-45

  Hirsh, Mark ^a,b   Kaplan, Viktoria ^a   Dyugovskaya, Larissa ^b   Krausz, Michael M ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Acute respiratory distress syndrome; Cecal ligation and puncture; Cytokine; Cytotoxicity; Inflammation; Natural killer cells

Indexed keywords

CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INJURY; LUNG BLOOD VESSEL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; SEPSIS; SYSTEMIC DISEASE;

ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLAMMATION; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; SEPSIS;

EID: 13644254625     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000129758.81361.45     Document Type: Article

References (41)

1. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, Le Tulzo Y, Moore EE, Abraham E: NF-κB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13:85-91, 2000.
2. Downey GP, Dong Q, Kruger J, Dedhar S, Cherapanov V: Regulation of neutrophil activation in acute lung injury. Chest 116:46S-54S, 1999.
3. Tam S, King DP, Beaman BL: Increase of γδT lymphocytes in murine lungs occurs during recovery from pulmonary infection by Nocardia asteroides. Infect Immun 69:6165-6171, 2001.
4. Standiford TJ, Merhad B, Tsai WC: Cytokines as mediators of lung innate immunity. In Marshall JC, Cohen J (eds.). Immune Response in the Critically Ill. Berlin: Springer Verlag, 2000, pp 140-154.
5. Hirsh M, Dyugovskaya L, Kaplan V, Krausz MM: Response of lung γδT cells to experimental sepsis in mice. Immunology 112:153-160, 2004.
6. Medzhitov R, Janeway CA Jr: Innate immune recognition and control of adaptive immune responses. Semin Immunol 10:351-353, 1998.
7. Rabinovic BA, Li J, Shannon J, Hurren R, Chalupny J, Cosman D, Miller RG: Activated, but not resting, T cells can be recognized and killed by sygenic NK cells. J Immunol 170:3572-3576, 2003.
8. Kos FJ, Engleman EG: Immune regulation: a critical link between NK cells and CTLs. Immunol Today 17:174-176, 1996.
9. + NKT cells in lipopolysaccharide-induced lethal shock in mice. J Immunol 169:1426-1432, 2002.
10. Carson WE, Yu H, Dierksheide J, Pfeffer K, Bouchard P, Clark R, Durbin J, Baldwin AS, Peschon J, Johnson PR, Ku G, Baumann H, Caligiuri MA: A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 162:4943-4951, 1999.
11. Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE III: Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 132:205-212, 2002.
12. + cells in experimental Staphylococcus aureus arthritis. Clin Exp Immunol 117:63-69, 1999.
13. Une C, Andersson J, Örn J: Role of IFN-α/β and IL-12 in the activation of the natural killer cells and interferon-γ production during experimental infection with Trypanosoma cruzi. Clin Exp Immunol 134:195-201, 2003.
14. Junqueira-Kipnis AP, Kipnis A, Jamieson A, Juarrero MG, Diefenbach A, Raulet DH, Turner J, Orme IM: NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol 171:6039-6045, 2003.
15. Delclaux C, Azoulay E: Inflammatory response to infectious pulmonary injury. Ear Respir J Suppl 42:10s-14s, 2003.
16. Godshall CJ, Scott MJ, Burch PT, Peyton JC, Cheadle WG: Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 19:144-149, 2003.
17. Seki S, Osada S-I, Ono S, Aosasa S, Habu Y, Nishikage T, Mochizuki H, Hiraide H: Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice. Infect Immun 66:5286-5294, 1998.
18. Hirsh M, Dyugovskaya L, Bashenko Y, Krausz MM: Reduced rate of bacterial translocation and improved variables of natural killer cell and T-cell activity in rats survived controlled hemorrhagic shock and treated with hypertonic saline. Crit Care Med 30:861-867, 2002.
19. Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide versus cecal ligation and puncture. Shock 13:110-116, 2000.
20. Bachofen M, Weibel ER: Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3:35-56, 1982.
21. Holt PG, Degebrodt A, Venaille T, O'Leary C, Krska K, Flexman J, Farrell H, Shellam G, Young P, Penhale J, et al.: Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 54:139-147, 1985.
22. Dyugovskaya L, Bashenko Y, Hirsh M, Krausz MM: The immune system state in the rat with hemorrhagic shock following massive splenic injury: phenotypic characteristics and immune potential of lymphocytes derived from central and periphery lymphoid organs. Shock 15:118-123, 2001.
23. Vitale M, Neri LM, Comani S, Falcieri E, Rizzoli R, Rana R, Papa S: Natural killer function in flow cytometry. II. Evaluation of NK lytic activity by means of target cell morphological changes detected by right angle light scatter. J Immunol Methods 121:115-120, 1989.
24. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
25. Mercer-Jones MA, Heinzelmann M, Peyton JC, Wickel DJ, Cook M, Cheadle WG: The pulmonary inflammatory response to experimental fecal peritonitis: relative roles of tumor necrosis factor-α and endotoxin. Inflammation 21:401-417, 1997.
26. Sherwood ER, Lin CY, Tao W, Hartmann CA, Dujon JE, French AJ, Varma TK: β2 Microglobulin knockout mice are resistant to lethal intraabdominal sepsis. Am J Resp Crit Care Med 167:1641-1649, 2003.
27. Yamada M, Tamura N, Shirai T, Kira S: Flow cytometric analysis of lymphocyte subsets in the bronchoalveolar lavage fluid and peripheral blood of healthy volunteers. Scand J Immunol 24:559-565, 1986.
28. Usui Y, Aida H, Kimula Y, Miura H, Takayama S, Nakayama M: Hypersensitivity pneumonitis induced by hexamethylene diisocyanate. Intern Med 31:912-916, 1992.
29. Lanier LL: Natural killer cells: from no receptors to too many. Immunity 6:371-378, 1997.
30. + T cells upon NKR-P1 cross-linking. J Exp Med 183:2391-2396, 1996.
31. Carlyle JR, Martin A, Mehra A, Attisano L, Tsui FW, Zuniga-Pflucker JC: Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol 162:5917-5923, 1999.
32. + T cells preferentially accumulate in human liver. Eur J Immunol 29:2406-2413, 1999.
33. Shau H, Roth MD, Golub SH: Regulation of natural killer function by nonlymphoid cells. Nature Immunol 12:235-249, 1993.
34. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189-220, 1999.
35. Biron CA: Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin Immunol 10:383-390, 1998.
36. Morrison BE, Park SJ, Mooney JM, Mehrad B: Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 112:1862-1870, 2003.
37. Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, Nomura T: Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 84:269-275, 1997.
38. Smyth MJ, Johnstone RW: Role of TNF in lymphocyte-mediated cytotoxicity. Microsc Res Tech 50:196-208, 2000.
39. Standiford TJ, Wilkowski JM, Sisson TH, Hattori N, Mehrad B, Bucknell KA, Moore TA: Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia. Hum Gene Ther 10:899-909, 1999.
40. Moore TA, Lau HY, Cogen AL, Monteleon CL, Standiford TJ: Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. Shock 20:309-315, 2003.
41. Wang KS, Frank DA, Ritz J: Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 95:3183-3190, 2000.